India records approximately 50,000 fatalities annually from snakebites, representing nearly half of the worldwide toll, according to the federal government figures. Some estimates suggest the true number of deaths between 2000 and 2019 may have averaged 58,000 per year, underlining a severe public health challenge, a 2020 study indicated.
A recent Global Snakebite Taskforce (GST) survey of 904 medical professionals across four highly affected nations found that 99% of Indian healthcare workers struggle with antivenom administration. These barriers—including poor infrastructure, scarce antivenom, and insufficient training—often result in severe patient complications such as amputations, reported nearly half of the surveyed professionals.
The World Health Organization classified snakebite envenoming as a 'highest priority neglected tropical disease' in 2017, given that over 100,000 people die globally each year. These incidents disproportionately impact vulnerable, rural communities in low and middle-income nations, particularly farmers in central and eastern India, noted GST member Dr. Yogesh Jain.
India launched the National Action Plan for Prevention and Control of Snakebite Envenoming (NAPSE) in 2024, aiming to halve fatalities by 2030 through improved surveillance and medical capacity. However, experts suggest implementation has been inconsistent, with Dr. Jain asserting that the lack of political mobilization stems from viewing it as solely 'a poor person's problem.'
Timely treatment is critical, as venom acts rapidly, but delays are common due to poor rural road networks and limited ambulance services preventing rapid transport to hospitals. Furthermore, many rural residents initially seek care from faith healers, further postponing effective medical intervention, according to reports cited by Dr. Jain.
Antivenom availability presents another significant constraint, as India primarily produces treatments targeting only the 'big four' venomous snakes, stated Gerry Martin, co-founder of The Liana Trust. Research from the All India Institute of Medical Sciences in Jodhpur last year showed that standard antivenom was ineffective in two-thirds of cases where the specific snake species was ultimately unknown.
Experts advocate for region-specific antivenoms to address the toxicity profiles of numerous other local species that exceed the scope of current treatments. Karnataka state has taken a step by mandating that snakebites be reported as a notifiable disease, a measure that experts like Martin believe should be widely adopted to combat under-reporting.
